Home > RVV Financials

Revive Therapeutics financials at a glance

Year	Year		2014	2015	2016	2017	2018	2019	2020	2021	2013	2022	2023	2024
Rev.	Revenue		C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M
GM %	Gross Margin %		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share		C$-0.09	C$0.00
Div.	Dividends		C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00
PR %	Payout Ratio %		0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares		0m	23.91m	23.94m	47.5m	54.8m	58.4m	72.41m	240.9m	0m	317.96m	324.88m	418.56m
OCF	Operating Cash Flow		C$-0.77M	C$-1.49M	C$-1.99M	C$-2.08M	C$-1.50M	C$-1.18M	C$-2.52M	C$-8.31M	C$-0.16M	C$-13.06M	C$-6.03M	C$0.00M
FCF	Free Cash Flow		C$-0.78M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M
FCFS	Free Cash Flow Per Share		C$-0.05	C$-0.07	C$-0.08	C$-0.04	C$-0.03	C$-0.02	C$-0.02	C$-0.04	C$-0.02	C$-0.04	C$-0.02	C$0.00

© Kit Invest S.L - StockForecast 2022. All rights reserved. Calle Alemania 3, 35100 San Bartolome de Tirajana, Spain | CIF: B57640591 Contact at [email protected]

StockForecast enables investors to make better investment decisions by providing financial data and objective market analysis. StockForecast has the objective information you need to analyze stocks and currencies. StockForecast is not a personal financial advisor and does not make recommendations or offers to buy or sell securities or currencies.